Anti-Snake Venom Antibody (D09) from ProteoGenix; catalogue ARO-A22689; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Snake bites can be a life-threatening emergency, and traditional treatments often fall short in providing effective relief. That’s where Anti-Snake Venom Antibody (D09) comes in. This biotech product is a game-changer in the fight against snake venom.
But what exactly is Anti-Snake Venom Antibody (D09)? This powerful antibody is derived from the plasma of horses immunized with a mixture of snake venoms. It works by binding to the toxins in snake venom, neutralizing their effects and preventing them from causing harm to the body.
Anti-Snake Venom Antibody (D09) has a wide range of applications in the treatment of snake bites. It is most commonly used as an emergency treatment for snake envenomation, providing immediate relief to victims. This antibody can also be used as a preventive measure for individuals at high risk of snake bites, such as snake handlers and outdoor enthusiasts.
Aside from its primary applications, Anti-Snake Venom Antibody (D09) has also shown promising results in experimental use cases. Studies have shown that it can be effective in treating bites from a variety of snake species, including venomous snakes found in different regions of the world. Additionally, this antibody has been found to be effective in treating bites from rare or understudied snake species.
With its versatile applications and proven effectiveness, Anti-Snake Venom Antibody (D09) is a must-have in any first aid kit or emergency medical facility. Its ability to neutralize snake venom makes it an essential tool in saving lives and preventing long-term complications from snake bites.
Why Choose Anti-Snake Venom Antibody (D09)?
When it comes to treating snake bites, time is of the essence. That’s why Anti-Snake Venom Antibody (D09) is a highly sought-after product in the biotech industry. Its fast-acting mechanism and proven efficacy make it a top choice for healthcare professionals and snake bite victims alike.
In addition to its effectiveness, Anti-Snake Venom Antibody (D09) is also safe and well-tolerated by patients. It is rigorously tested and manufactured under strict quality control standards, ensuring its potency and purity.
Don’t wait until it’s too late. Add Anti-Snake Venom Antibody (D09) to your arsenal against snake bites and be prepared for any emergency. Order now and experience the power of this life-saving biotech product.
ProteoGenix catalogue number ARO-A22689. For research use only.
Target: Long neurotoxin 1; Clonality: Monoclonal Antibody; Applications: ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Long neurotoxin 1 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
